ConcertAI
ConcertAI specializes in real-world data and AI technologies for oncology, offering products and services to improve patient care and optimize clinical trials.
Company Overview
ConcertAI specializes in real-world data (RWD) and artificial intelligence (AI) technologies for oncology. They offer a wide range of products and services designed to leverage real-world data and advanced AI models to improve cancer care and research. With key partnerships in the biopharma and healthcare sectors, ConcertAI is at the forefront of next-generation clinical trials and oncology research.
Products and Solutions
ConcertAI offers a variety of products and services, including Real-World Data Products, Digital Trial Solutions, Clinical Trial Optimization, Predictive Patient, and Commercial Solutions. Key products include STAR, an enterprise, HIPAA-compliant solution for actionable patient insights; and RWD360™, Patient360™, and Genome360™ data products. Their Predictive Patient product uses advanced AI models to improve patient experience from therapy initiation through adherence.
Initiatives and Partnerships
ConcertAI drives several multidisciplinary initiatives such as ERACE (Engaging Research to Achieve Cancer Care Equity), aimed at addressing cancer disparities through data-driven research. They also have strategic partnerships with companies like Caris Life Sciences, AbbVie, and NeoGenomics to accelerate oncology pipeline development and clinical trials. These collaborations focus on advancing hematological research and generative AI solutions.
Research and Publications
ConcertAI conducts extensive research on treatment patterns, clinical outcomes, and healthcare costs across various cancer types. Their publications cover topics like adherence, adverse events, clinical outcomes, and survival outcomes in oncology. The company's data products are enriched with AI models and linked to claims data for comprehensive patient insights, supporting studies on a wide range of cancers including AML, bladder, breast, gastric-esophageal, lung, liver, melanoma, multiple myeloma, pancreatic, prostate, and renal cancers.
CancerLinQ Platform
CancerLinQ, a real-world data platform, is now part of ConcertAI. It serves as a comprehensive database for oncology research, providing key insights into patient journeys and clinical outcomes. The platform supports ConcertAI's mission to enhance cancer care through data-driven solutions, allowing for optimized patient experiences and better adherence trends.